Cite
MLA Citation
J. Van Wyk et al.. “Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study).” Journal of infection and public health, vol. 13, no. 2, 2020, pp. 349–. http://access.bl.uk/ark:/81055/vdc_100099964386.0x000015